Bishai
James Bishai, Allston, MA US
Patent application number | Description | Published |
---|---|---|
20100096805 | CUSTOMIZABLE GAME DEVICES - A game board device can be customizable with displayable objects. An exemplary game board device can comprise a game board panel, a playing area, and a carrying system. The game board panel can be a base for the game board device and can comprise at least one window. The playing area can be a top surface of the game board panel, and can comprise a game board design integrating the window. Game play of a board game can occur in the playing area, and the game board design can correspond to a board for a board game. The carrying system can be attachable to the game board panel. The carrying system can comprise at least one carrying device configured to position a displayable object viewable through the window. | 04-22-2010 |
Nadia Bishai, Dorval CA
Patent application number | Description | Published |
---|---|---|
20110080905 | METHOD AND INTERNET PROTOCOL SHORT MESSAGE GATEWAY (IP-SM-GW) FOR PROVIDING AN INTERWORKING SERVICE BETWEEN CONVERGED IP MESSAGING (CPM) AND SHORT MESSAGE SERVICE (SMS) - A method and an IP-SM-GW for providing an interworking service between CPM and SMS are provided. The method comprises the steps of receiving a chat session invitation, in a IP-SM-GW, the chat session invitation originating from a CPM UE and being sent toward an SMS enabled UE. Assigning an identifier with the chat session in the IP-SM-GW and sending an invitation acknowledgement from the IP-SM-GW to the CPM UE. Receiving a message containing data, within the chat session, in the IP-SM-GW, from the CPM UE and being sent to the SMS enabled UE, formatting the message into an SMS message, wherein the identifier assigned to the chat session is inserted as a sender of the SMS message to ensure that an SMS response is sent back to the IP-SM-GW and forwarding the formatted SMS message to the SMS enabled UE. | 04-07-2011 |
William Bishai, Towson, MD US
Patent application number | Description | Published |
---|---|---|
20110218220 | RATIONALLY IMPROVED ISONIAZID AND ETHIONAMIDE DERIVATIVES AND ACTIVITY THROUGH SELECTIVE ISOTOPIC SUBSTITUTION - The present invention relates to the use of isotopically labeled derivatives of isoniazid, ethionamide and related compounds as effective therapy for the treatment of mycobacterial diseases, including | 09-08-2011 |
20130150415 | RATIONALLY IMPROVED ISONIAZID AND ETHIONAMIDE DERIVATIVES AND ACTIVITY THROUGH SELECTIVE ISOTOPIC SUBSTITUTION - The present invention relates to the use of isotopically labeled derivatives of isoniazid, ethionamide and related compounds as effective therapy for the treatment of mycobacterial diseases, including | 06-13-2013 |
William R. Bishai, Baltimore, MD US
Patent application number | Description | Published |
---|---|---|
20080241182 | MYCOBACTERIUM TUBERCULOSIS PERSISTANCE GENES - Compositions and methods for preventing | 10-02-2008 |
William R. Bishai, Towson, MD US
Patent application number | Description | Published |
---|---|---|
20120115835 | METHODS FOR TREATMENT OF BACTERIAL INFECTIONS - The peptidoglycan layer is a vital component of the bacterial cell wall, which comprises 4→3 and 3→3 transpeptide cross-linkages, the formation of which are catalyzed by D,D- and L,D-transpeptidases, respectively. Methods for the treatment of bacterial infections with agents that inhibit L,D-transpeptidases, either alone or in combination with D,D-transpeptidase inhibitors, are provided herein. Also provided are methods for the treatment of chronic stage tuberculosis with agents that inhibit enzyme with L,D-transpeptidase activity. | 05-10-2012 |
20140342364 | METHODS FOR TREATMENT OF BACTERIAL INFECTIONS - The peptidoglycan layer is a vital component of the bacterial cell wall, which comprises 4→3 and 3→3 transpeptide cross-linkages, the formation of which are catalyzed by D,D- and L,D-transpeptidases, respectively. Methods for the treatment of bacterial infections with agents that inhibit L,D-transpeptidases, either alone or in combination with D,D-transpeptidase inhibitors, are provided herein. Also provided are methods for the treatment of chronic stage tuberculosis with agents that inhibit enzyme with L,D-transpeptidase activity. | 11-20-2014 |